Departamento de Parasitologia, Instituto de Ciências Biomédicas, Universidade de São Paulo, Av. Prof. Lineu Prestes, Lab. 41, São Paulo, SP, Brazil.
Vet Parasitol. 2010 Feb 26;168(1-2):97-104. doi: 10.1016/j.vetpar.2009.10.003. Epub 2009 Oct 12.
Resistance to ivermectin (IVM) in field populations of Rhipicephalus microplus of Brazil has been observed since 2001. In this work, four selection methods (infestations with: (1) IVM-treated larvae; (2) larvae from IVM-treated adult female ticks; (3) larvae from IVM-treated adult female ticks on an IVM-treated host; and (4) larvae obtained from IVM-treated females that produced eggs with a high eclosion rate) were used on a field population with an initial ivermectin (IVM) resistance ratio at LC50 (RR50) of 1.37 with the objective to obtain experimentally a highly-resistant strain. After ten generations, using these methods combined, the final RR50 was 8.06. This work shows for the first time that it was possible to increase IVM resistance in R. microplus in laboratory conditions. The establishment of a drug resistant R. microplus strain is a fundamental first step for further research into the mechanisms of ivermectin-resistance in R. microplus and potentially methods to control this resistance.
自 2001 年以来,巴西的 Rhipicephalus microplus 田间种群已出现对伊维菌素(IVM)的耐药性。在这项工作中,使用了四种选择方法(感染:(1)用 IVM 处理过的幼虫;(2)来自用 IVM 处理过的成年雌性蜱的幼虫;(3)来自用 IVM 处理过的成年雌性蜱并在 IVM 处理过的宿主上的幼虫;和(4)从产生高孵化率卵的用 IVM 处理过的雌性中获得的幼虫)对初始伊维菌素(IVM)LC50(RR50)耐药率为 1.37 的田间种群进行处理,目的是获得具有高度耐药性的菌株。经过十代,使用这些方法相结合,最终 RR50 达到 8.06。这项工作首次表明,在实验室条件下有可能增加 R. microplus 对 IVM 的耐药性。建立抗药性 R. microplus 菌株是进一步研究 R. microplus 伊维菌素耐药机制以及潜在控制这种耐药性方法的重要第一步。